Bausch & Lomb BLCO
NYSE BLCO
$17.24 +0.04 (+0.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch & Lomb (BLCO) Cash from Financing Activities (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Cash from Financing Activities came in at $34.0 million in Q2 2026, down 62.22% YoY from $90.0 million in Q2 2025, and up 270.0% on a QoQ basis from -$20.0 million in Q1 2026.

Bausch & Lomb (BLCO) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has 6 years of Cash from Financing Activities data on file, last reported at $34.0 million in Q2 2026.

  • Quarterly Cash from Financing Activities fell 62.22% year-over-year to $34.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $118.0 million (down 52.23% YoY) and the FY2025 annual result came in at $225.0 million, up 26.4% from the prior year.
  • Cash from Financing Activities grew to $34.0 million in Q2 2026, from -$20.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.8 billion in Q3 2023 to a low of -$109.0 million in Q3 2022.
  • A 5-year average of $143.1 million and a median of $46.0 million in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities surged 1761.47% — and 2026, when it slumped 164.52%.
  • Tracing BLCO's Cash from Financing Activities over 5 years: stood at -$7.0 million in 2022, then soared by 1328.57% to $86.0 million in 2023, then soared by 69.77% to $146.0 million in 2024, then fell by 20.55% to $116.0 million in 2025, then slumped by 70.69% to $34.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at $34.0 million (Q2 2026), -$20.0 million (Q1 2026), and $116.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -287.90 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -577.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -510.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -263.16 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -159.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -164.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -300.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -75.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -31.00 Mn
10 Bausch & Lomb 6.14 Bn 5.76 Bn 867.00 Mn 34.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 34.00 Mn
Jun 30, 2026 34.00 Mn
Mar 31, 2026 -20.00 Mn
Mar 31, 2026 -20.00 Mn
Dec 31, 2025 116.00 Mn
Dec 31, 2025 116.00 Mn
Sep 30, 2025 -12.00 Mn
Sep 30, 2025 -12.00 Mn
Jun 30, 2025 90.00 Mn
Jun 30, 2025 90.00 Mn
Mar 31, 2025 31.00 Mn
Mar 31, 2025 31.00 Mn
Dec 31, 2024 146.00 Mn
Dec 31, 2024 146.00 Mn
Sep 30, 2024 -20.00 Mn
Sep 30, 2024 -20.00 Mn
Jun 30, 2024 40.00 Mn
Jun 30, 2024 40.00 Mn
Mar 31, 2024 12.00 Mn
Mar 31, 2024 12.00 Mn